Escitalopram: a review of its use in the management of major depressive disorder.
about
Depression in vascular pathologies: the neurologist's point of view.Managing depressive and anxiety disorders with escitalopram.Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability.Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.The use of escitalopram beyond major depression: pharmacological aspects, efficacy and tolerability in anxiety disorders.Escitalopram for the treatment of major depression and anxiety disorders.Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).Predictive factors for generalized seizures after deliberate citalopram overdoseThe estimation of utility weights in cost-utility analysis for mental disorders: a systematic review.Pharmacokinetics of antidepressants in patients with hepatic impairment.New treatment options for OCD.R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.Copper-catalyzed cyanation of heterocycle carbon-hydrogen bonds.Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines.Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders.
P2860
Q35122942-4F0F8BA4-F239-471A-860F-5E28A56F5135Q36407369-3BD375C1-FC9C-4BC5-94B0-FF850B77A389Q36479510-82DCAB50-C9E3-4AD3-9359-466C0EE6C084Q36902050-4AD9660B-28C9-470F-855B-93790B4C9C8CQ36960563-C6EB8552-9963-4B34-85F5-EF1F08360AB9Q37139768-6CCD703D-BE16-427E-BDAD-39AC58B3648BQ37171411-FD4F7CA6-A472-4D87-B801-5844F32E547AQ37175817-343B24A8-C6C3-4CE5-A338-12A217DEF316Q38167693-6741D6F7-F80C-4367-BEE7-4B8750B9135EQ38253564-654B70BB-FD1D-4FCD-9BE1-375E99EA9300Q39341666-1713E54C-CA99-4055-8310-B71472261686Q40769483-25ADD36B-C932-446C-8BF4-E5BD22B2DA5CQ40898610-BD541865-5509-4E4D-BFF9-4C20398DB935Q41880908-AADBB448-4F59-4A81-9E1B-EAEB9418B762Q44355507-01A3DACD-DE47-487F-BF3F-4D5203FB5879
P2860
Escitalopram: a review of its use in the management of major depressive disorder.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Escitalopram: a review of its use in the management of major depressive disorder.
@ast
Escitalopram: a review of its use in the management of major depressive disorder.
@en
type
label
Escitalopram: a review of its use in the management of major depressive disorder.
@ast
Escitalopram: a review of its use in the management of major depressive disorder.
@en
prefLabel
Escitalopram: a review of its use in the management of major depressive disorder.
@ast
Escitalopram: a review of its use in the management of major depressive disorder.
@en
P1433
P1476
Escitalopram: a review of its use in the management of major depressive disorder
@en
P2093
David Murdoch
P304
P356
10.2165/00003495-200565160-00013
P50
P577
2005-01-01T00:00:00Z
P6179
1025975035